Literature DB >> 15233549

A novel splice variant involving the 5' untranslated region of thyroid hormone receptor beta1 (TRbeta1).

D Mannavola1, L C Moeller, P Beck-Peccoz, L Persani, R E Weiss, S Refetoff.   

Abstract

The thyroid hormone receptor beta (TRbeta) gene generates two different proteins by use of a different promoter (beta1 and beta2). We now report a novel short TRbeta1 RNA splice variant in humans lacking 35 nucleotides at the 3' end of the non-coding exon 1 due to an alternative 5' splice donor site. This short variant was first identified in sequences of cDNA obtained from cultured human fibroblasts. Both variants were found in human fibroblasts, brain, pituitary, adrenal gland, placenta, muscle, thyroid and lymphocytes. These TRbeta1 variants possess splice donor sites with a sequence score slightly favoring the TRbeta1 long variant. Variant-specific real-time polymerase chain reaction (PCR) showed that their relative proportions were equal except in pituitary and muscle, in which the long form was 3- and 5-fold in excess. T3 treatment of fibroblasts grown in thyroid hormone depleted medium did not affect the absolute or relative expression of the two variants. Furthermore, the expression level in fibroblasts from patients with resistance to thyroid hormone with or without TRbeta gene mutations was not different to that in fibroblasts from normal controls.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15233549     DOI: 10.1007/bf03351055

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  13 in total

1.  Five new families with resistance to thyroid hormone not caused by mutations in the thyroid hormone receptor beta gene.

Authors:  J Pohlenz; R E Weiss; P E Macchia; S Pannain; I T Lau; H Ho; S Refetoff
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

Review 2.  Physiological and molecular basis of thyroid hormone action.

Authors:  P M Yen
Journal:  Physiol Rev       Date:  2001-07       Impact factor: 37.312

Review 3.  Thyroid hormone receptors: multiple forms, multiple possibilities.

Authors:  M A Lazar
Journal:  Endocr Rev       Date:  1993-04       Impact factor: 19.871

4.  Search for abnormalities of nuclear corepressors, coactivators, and a coregulator in families with resistance to thyroid hormone without mutations in thyroid hormone receptor beta or alpha genes.

Authors:  S Reutrakul; P M Sadow; S Pannain; J Pohlenz; G A Carvalho; P E Macchia; R E Weiss; S Refetoff
Journal:  J Clin Endocrinol Metab       Date:  2000-10       Impact factor: 5.958

5.  Thyroid hormone inhibits fibronectin synthesis by cultured human skin fibroblasts.

Authors:  Y Murata; P Ceccarelli; S Refetoff; A L Horwitz; N Matsui
Journal:  J Clin Endocrinol Metab       Date:  1987-02       Impact factor: 5.958

6.  Cloning and characterization of the human thyroid hormone receptor beta 1 gene promoter.

Authors:  A Sakurai; T Miyamoto; L J DeGroot
Journal:  Biochem Biophys Res Commun       Date:  1992-05-29       Impact factor: 3.575

7.  Resistance to thyroid hormone diagnosed by the reduced response of fibroblasts to the triiodothyronine-induced suppression of fibronectin synthesis.

Authors:  P Ceccarelli; S Refetoff; Y Murata
Journal:  J Clin Endocrinol Metab       Date:  1987-08       Impact factor: 5.958

8.  Hormonal regulation of glycosaminoglycan accumulation in fibroblasts from patients with resistance to thyroid hormone.

Authors:  Y Murata; S Refetoff; A L Horwitz; T J Smith
Journal:  J Clin Endocrinol Metab       Date:  1983-12       Impact factor: 5.958

9.  Regulation of glycosaminoglycan synthesis by thyroid hormone in vitro.

Authors:  T J Smith; Y Murata; A L Horwitz; L Philipson; S Refetoff
Journal:  J Clin Invest       Date:  1982-11       Impact factor: 14.808

10.  Identical mutations in unrelated families with generalized resistance to thyroid hormone occur in cytosine-guanine-rich areas of the thyroid hormone receptor beta gene. Analysis of 15 families.

Authors:  R E Weiss; M Weinberg; S Refetoff
Journal:  J Clin Invest       Date:  1993-06       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.